Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ENVB
ENVB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ENVB News
Enveric Biosciences Reports Q4 2025 Financial Results
2d ago
seekingalpha
Enveric Biosciences Advances EB-003 Clinical Research
4d ago
stocktwits
ENVB Stock Falls in After-Hours Trading Due to Increased Q4 Losses Despite Advancements in Psychiatry Drug Research
4d ago
stocktwits
Enveric Biosciences Advances EB-003 Drug Development with Positive Preclinical Results
4d ago
Newsfilter
ENVERIC BIOSCIENCES ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS AND CORPORATE UPDATE
4d ago
moomoo
ENVERIC BIOSCIENCES INC: Q4 REPORTS NET LOSS OF $6.12 PER SHARE
4d ago
moomoo
Enveric Biosciences Secures Canadian Trademark Registration
Mar 18 2026
Newsfilter
Enveric Biosciences Patent Challenge Withdrawn
Feb 25 2026
stocktwits
Enveric Biosciences Patent Challenge Withdrawn
Feb 25 2026
Benzinga
Weekly Roundup: Cannabis and Psychedelic Sector Developments
Feb 23 2026
Yahoo Finance
Enveric Biosciences Reveals New Data on EB-003
Feb 19 2026
Benzinga
Enveric Biosciences Closes Direct Offering of Common Stock
Jan 28 2026
Yahoo Finance
Enveric Biosciences Announces Direct Offering of Shares
Jan 28 2026
seekingalpha
Enveric Secures U.S. Patent Expanding Neuropsychiatric Drug Development
Dec 29 2025
Newsfilter
ENvue Appoints David Johnson as Chairman to Drive Feeding Tube Technology Advancement
Dec 15 2025
Newsfilter
Enveric Biosciences Exercises 426,390 Warrants at $7.05 Each, Raising $3.1 Million
Dec 12 2025
Newsfilter
Show More News
